Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$392.31M
Total Bought
$23.64M
Total Sold
$5.58M
Net Transaction
+$18.05M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
VANGUARD INTL EQUITY INDEX F2,990,0843,243,484+253,400219,951243,58662.09%+23,635
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41008,09312,5363.20%+4,442
VANGUARD INDEX FDS520,000520,000099,315102,02426.01%+2,709
ALECTOR INC1,307,8581,307,85802,0402,8120.72%+772
SURROZEN INC87,69687,69601,9822,5550.65%+573
SURROZEN INC170,833170,8330330.00%-1
TENAYA THERAPEUTICS INC1,015,7051,015,70507237030.18%-19
PMV PHARMACEUTICALS INC2,627,6432,627,64303,2853,2580.83%-26
FOGHORN THERAPEUTICS INC1,573,7611,573,76108,4987,5231.92%-976
ISHARES TR
MSCI INDIA ETF
369,600369,600019,97717,3124.41%-2,665
RAPT THERAPEUTICS INC82,2340-82,2342,7850-2,785
SPDR S&P 500 ETF TR(SPY)4,1040-4,1042,7990-2,799
Page 1 of 1